GlaxoSmithKline News and Research

RSS

Vodafone partners with GSK, GAVI to use, study mobile technology to improve vaccination rates

"British mobile phone group Vodafone and drug maker GlaxoSmithKline are joining forces on a novel project to increase childhood vaccination rates in Mozambique using text messaging," Reuters reports.

10 Dec 2012

GSK, MD Anderson partner to develop new therapeutic antibodies against cancer

The University of Texas MD Anderson Cancer Center and GlaxoSmithKline (GSK) have signed a research collaboration and license agreement to develop new therapeutic antibodies that promote an immune system attack against cancer.

10 Dec 2012

Government announces fraud collections hit record $5 billion

The Justice Department's civil division recovered a record $5 billion in the past fiscal year from companies that defrauded taxpayers, with much of the abuse occurring in the health care and mortgage industries.

6 Dec 2012

Pharma companies improving access to medicines but lack oversight of outsourced clinical trials, analysis says

Pharmaceutical companies are showing "greater accountability in the boardroom today over access to medicines, with more openness, targets and investment in drugs relevant to the poor," but they "show no evidence that they adequately supervise the conduct of outsourced clinical drug trials, according to a new analysis released on Wednesday," the Financial Times reports.

29 Nov 2012

GSK receives FDA approval for PROMACTA to treat thrombocytopenia

GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved PROMACTA for the treatment of thrombocytopenia (low blood platelet counts) in patients with chronic hepatitis C to allow them to initiate and maintain interferon-based therapy.

19 Nov 2012

Interim results from RTS,S vaccine on-going phase III trial on malaria

According to the World Health Organization (WHO), more than 250 million clinical malaria cases are attributed to Plasmodium falciparum (Pf) annually, with over 1.1 million deaths in sub-Saharan Africa alone.

17 Nov 2012

Scientists to develop hydrogels that can be injected into patients to form active biological scaffolds

Smart scaffolding that can guide cells, proteins and small-molecule drugs to make new tissue and repair damage inside the body is in the works at Rice University.

14 Nov 2012

Malaria vaccine reduced severe and uncomplicated malaria by a third in young infants when given with other routine vaccines

Experts from the London School of Hygiene & Tropical Medicine today comment on the results of a malaria vaccine trial.

9 Nov 2012

RTS,S vaccine candidate can help protect African infants against malaria

International African Vaccinology Conference, Cape Town, South Africa-Results from a pivotal, large-scale Phase III trial, published online today in the New England Journal of Medicine, show that the RTS,S malaria vaccine candidate can help protect African infants against malaria.

9 Nov 2012

Alnylam third quarter 2012 revenues decrease to $16.8 million

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today reported its consolidated financial results for the third quarter 2012, and company highlights.

6 Nov 2012

SSRIs should be prescribed with great caution to those attempting to get pregnant

Elevated risk of miscarriage, preterm birth, neonatal health complications and possible longer term neurobehavioral abnormalities, including autism, suggest that a class of antidepressants known as selective serotonin reuptake inhibitors (SSRI) should only be prescribed with great caution and with full counseling for women experiencing depression and attempting to get pregnant, say researchers at Beth Israel Deaconess Medical Center, Tufts Medical Center and MetroWest Medical Center.

31 Oct 2012

Hospitals, health care companies prepped for hurricane fallout

The health care world prepped for Hurricane Sandy by moving patients and shutting down offices.

31 Oct 2012

SSRIs should be prescribed with great caution to those attempting to get pregnant

31 Oct 2012

GlaxoSmithKline introduces Complete the Cycle Recycle Program for GSK Respiratory Inhalers

GlaxoSmithKline plc has introduced a new program to help consumers recycle their empty GSK respiratory inhalers and keep waste out of landfills.

25 Oct 2012

Thrasos completes $35 Million financing for development of THR-184 against AKI

Thrasos Therapeutics announced that it has completed a $35 Million (U.S.) financing for the development of THR-184, its lead product candidate for the treatment of acute kidney injury (AKI).

25 Oct 2012

AAPS recognizes top scientists in pharmaceutical sciences

During the Opening Session of the 2012 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, AAPS President David Y. Mitchell, Ph.D., presented the following ground-breaking researchers with awards commemorating their contributions to the pharmaceutical sciences:

15 Oct 2012

GlaxoSmithKline to make clinical trial data available to other researchers

GlaxoSmithKline (GSK) CEO Andrew Witty "said on Thursday detailed data from its clinical trials would be made available to other researchers," Reuters reports, adding, "That would include anonymized patient-level results that sit behind clinical trials of approved and failed drugs."

15 Oct 2012

Menstrual cycle alters muscle activation patterns in female athletes

Numerous studies have shown that female athletes are more likely to get knee injuries, especially anterior cruciate ligament (ACL) tears and chronic pain, than their male counterparts.

12 Oct 2012

T cells become more responsive in cancer survivors after exercise

Researchers may soon be able to add yet another item to the list of exercise's well-documented health benefits: A preliminary study suggests that when cancer survivors exercise for several weeks after they finish chemotherapy, their immune systems remodel themselves to become more effective, potentially fending off future incidences of cancer.

12 Oct 2012

Exercise can help slow down premature cardiovascular aging effects of type 2 diabetes

One of life's certainties is that everyone ages. However, it's also certain that not everyone ages at the same rate. According to recent research being presented this week, the cardiovascular system of people with type 2 diabetes shows signs of aging significantly earlier than those without the disease.

11 Oct 2012

GlaxoSmithKline News and Research

Vodafone partners with GSK, GAVI to use, study mobile technology to improve vaccination rates

GSK, MD Anderson partner to develop new therapeutic antibodies against cancer

Government announces fraud collections hit record $5 billion

Pharma companies improving access to medicines but lack oversight of outsourced clinical trials, analysis says

GSK receives FDA approval for PROMACTA to treat thrombocytopenia

Interim results from RTS,S vaccine on-going phase III trial on malaria

Scientists to develop hydrogels that can be injected into patients to form active biological scaffolds

Malaria vaccine reduced severe and uncomplicated malaria by a third in young infants when given with other routine vaccines

RTS,S vaccine candidate can help protect African infants against malaria

Alnylam third quarter 2012 revenues decrease to $16.8 million

SSRIs should be prescribed with great caution to those attempting to get pregnant

Hospitals, health care companies prepped for hurricane fallout

SSRIs should be prescribed with great caution to those attempting to get pregnant

GlaxoSmithKline introduces Complete the Cycle Recycle Program for GSK Respiratory Inhalers

Thrasos completes $35 Million financing for development of THR-184 against AKI

AAPS recognizes top scientists in pharmaceutical sciences

GlaxoSmithKline to make clinical trial data available to other researchers

Menstrual cycle alters muscle activation patterns in female athletes

T cells become more responsive in cancer survivors after exercise

Exercise can help slow down premature cardiovascular aging effects of type 2 diabetes

Industry Focus eBook - Cell biology (5th edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News